These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32389425)

  • 1. The association between follicle size and oocyte development as a function of final follicular maturation triggering.
    Mohr-Sasson A; Orvieto R; Blumenfeld S; Axelrod M; Mor-Hadar D; Grin L; Aizer A; Haas J
    Reprod Biomed Online; 2020 Jun; 40(6):887-893. PubMed ID: 32389425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does a Large (>24 mm) Follicle Yield a Competent Oocyte/Embryo?
    Orvieto R; Mohr-Sasson A; Blumenfeld S; Nahum R; Aizer A; Haas J
    Gynecol Obstet Invest; 2020; 85(5):416-419. PubMed ID: 32966987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval.
    Wirleitner B; Okhowat J; Vištejnová L; Králíčková M; Karlíková M; Vanderzwalmen P; Ectors F; Hradecký L; Schuff M; Murtinger M
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):118-125. PubMed ID: 29134715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R
    J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?
    Lainas GT; Lainas TG; Sfontouris IA; Chatzimeletiou K; Venetis CA; Bosdou JK; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
    Hum Reprod; 2019 Sep; 34(9):1770-1777. PubMed ID: 31384921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Follicles of Obese Patients Yield Competent Oocytes/Embryos?
    Orvieto R; Mohr-Sasson A; Aizer A; Nahum R; Blumenfeld S; Kirshenbaum M; Haas J
    Gynecol Obstet Invest; 2020; 85(3):290-294. PubMed ID: 32485714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering method in assisted reproduction alters the cumulus cell transcriptome.
    Fuchs Weizman N; Wyse BA; Gat I; Balakier H; Sangaralingam M; Caballero J; Kenigsberg S; Librach CL
    Reprod Biomed Online; 2019 Aug; 39(2):211-224. PubMed ID: 31138495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituting HCG with GnRH agonist to trigger final follicular maturation--a retrospective comparison of three different ovarian stimulation protocols.
    Orvieto R; Rabinson J; Meltzer S; Zohav E; Anteby E; Homburg R
    Reprod Biomed Online; 2006 Aug; 13(2):198-201. PubMed ID: 16895632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of follicular size categories on oocyte quality at trigger day in young and advanced-age patients undergoing GnRH-ant therapy.
    Yang J; Gao J; Wang Y; Liu H; Lian X
    Front Endocrinol (Lausanne); 2023; 14():1167395. PubMed ID: 37124736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.
    Griesinger G; Diedrich K; Devroey P; Kolibianakis EM
    Hum Reprod Update; 2006; 12(2):159-68. PubMed ID: 16254001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis.
    Ding N; Liu X; Jian Q; Liang Z; Wang F
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():92-98. PubMed ID: 28957685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles.
    Hu X; Luo Y; Huang K; Li Y; Xu Y; Zhou C; Mai Q
    Medicine (Baltimore); 2016 May; 95(20):e3691. PubMed ID: 27196479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.
    Friis Wang N; Skouby SO; Humaidan P; Andersen CY
    Hum Reprod; 2019 May; 34(5):942-948. PubMed ID: 30927415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study.
    Lainas GT; Lainas TG; Sfontouris IA; Venetis CA; Bosdou JK; Chatzimeletiou A; Grimbizis GF; Tarlatzis BC; Kolibianakis EM
    Reprod Biomed Online; 2020 Jan; 40(1):168-175. PubMed ID: 31839394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A follicular volume of >0.56 cm
    Rodríguez-Fuentes A; Hernández J; Rouleau JP; Martín-Vasallo P; Palumbo A
    Fertil Steril; 2024 Jun; 121(6):991-999. PubMed ID: 38295896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association among diameter and volume of follicles, oocyte maturity, and competence in intracytoplasmic sperm injection cycles.
    Akbariasbagh F; Lorzadeh N; Azmoodeh A; Ghaseminejad A; Mohamadpoor J; Kazemirad S
    Minerva Ginecol; 2015 Oct; 67(5):397-403. PubMed ID: 26491821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes.
    Zilberberg E; Haas J; Dar S; Kedem A; Machtinger R; Orvieto R
    Gynecol Endocrinol; 2015 Feb; 31(2):145-7. PubMed ID: 25385007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; Aboulfoutouh I; Khattab SM; van Wely M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008046. PubMed ID: 21249699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.